ester of pluramycin (5) or neopluramycin (6) and suggests some other type of ester functionality. HRFAB-MS in the positive ion mode gave an (M+H)+ (peak matched) parent ion at m/z 912.3645 (calcd 912.3654) for altromycin A (1), indicating a molecular formula of C46H57NO18. DC1-D2Oexchange experiments in a deuteroglycerol matrix gave a deuterated (M +D)+ parent peak of 919, indicating six exchangeable protons in altromycin A. Altromycin B (2) gave an (M +H)+ parent mass of 926.3828 (calcd 926.3810) indicating a molecular formula of C47H59NO18(five exchangeables). The (M + H)+ parent mass of altromycin C (3) was 896.3686 (calcd 896.3705) indicating C46H57NO17 (five exchangeables) and the (M + H)+ for altromycin D (4) was 910.3868 (calcd 910.3861) indicating C47H59NO17 (four exchangeables). These formulae set the altromycins apart from any of the knownantibiotics of the pluramycin type.
Structure Determination
The UV/visible absorption spectra characterized the chromophore of the altromycins as an anthraquinone-y-pyrone, similar to that of hedamycin (7) and kidamycin (8) . This was confirmed by *H and 13C NMR studies, which included HETCOR7) and comparison with published data for hedamycin, kidamycin8) and ankinomycin (10)9).
In the *H NMR, characteristic singlets are seen at 56.5 (3-H) for the single proton on the pyrone (A) ring and <58.7 (6-H) for the single proton on the B ring. C-8 of the anthraquinone nucleus in the altromycins is not substituted as evidenced by the attached proton (in HETCOR data) which couples in an ABspin pattern to 9-H. This lack of substitution was without precedent until the recent CH3  CH  CH3  Q  CH3  CH  CH  CH  CH  CH2  CH  CH3  CH3   CH  CH  Q   CH2   CH   CH3  CH3  CH3  CH  CH2  CH  CH  CH  CH3  CH3 167 description of ankinomycin; all previously described pluramycins carry a C-glycosidically bound angolosamine moiety at C-8. Direct comparison of carbon resonances with published data, with appropriate allowances for the lack of substitution at C-8 and the structural elaboration at C-13 enabled assignment of the carbons of the chromophore (Table 1 ). These were supported by multiplicity analysis using the DEPT technique and by one bond and long range HETCORdata (Fig. 3) . A second major structural variation from known pluramycins is evident by the lack of a methyl carbon corresponding to C-13 which shows resonance at ca. 24ppm.In contrast, this carbon in the altromycins is assigned as a quaternary carbon at approximately 80ppm. This carbon is presumably derived from the C-2 carbon of the ultimate acetate unit in the polyketide precursor. This is supported by a single precedent for the altromycin type structure in which the carboxyl carbon of that unit has been retained in the final product (antibiotic SS43405D)10). The nature of substituents at C-13 in the altromycins will be discussed after consideration of the sugar moieties. Despite the absence of angolosamine on C-8 in the altromycins, the molecular formula indicates a larger molecule than the common pluramycins. The altromycins showa common loss of 144 amuin FAB-MS(positive ion mode) with resultant fragment ions indicating the loss of a neutral sugar. These fragment ions are in the molecular weight range of previously reported pluramycin compounds (~688~770 amu)11*, suggesting a more complex structure for the altromycins (895~925 amu).
The long range HETCOR experiments along with 13C NMRDEPT data enabled the construction of three separate sugar moieties associated with the altromycin chromophore. The HETCOR data indicated two neutral sugars and Af,iV-dimethylvancosamine (7V-methylvancosamine is found in altromycins A and C). The neutral sugars were shown to have anomeric and pseudoanomeric carbons at ca. 94ppm (C-l'") and 73ppm (C-6'), indicating an O-glycosyl and C-glycosyl linkage, respectively. The sugar A^JV-dimethylvancosamine, normally found in the pluramycins at C-10 on the chromophore, was also found to be at this location in the altromycins (evidenced by a HETCORcoupling: C-6" to 9-H and C-9, C-10, C-l 1 to 6"-H). A strong HETCORcoupling between the anomeric C-l'" of the neutral O-glycosidic sugar and 3"-H of the vancosamine moiety indicates that these two units are linked as a novel disaccharide at C-10. The quaternary C-13 near 80ppm showed HETCORcouplings to both 6-H of the chromophore and 6'-H of the other C-glycosidic sugar moiety. In addition, a 2D / correlated map experiment (COSY) demonstrated a long range coupling between 6-H and 6'-H. HETCORcouplings to 6'-H were also seen MAR. 1990 2 -CH3 4 -OCH3 from the carbonyl of a methyl ester and a quaternary carbon near 149ppm, C-5 of the chromophore. These data assigned C-13 to the role of a bridging carbon between the chromophore and the neutral C-glycosidic sugar which is substituted with a methyl ester group. Chemical shift along with molecular formula considerations lead to a hydroxyl group also being placed on this carbon. The quaternary carbon (C-14) of a simple dimethyl epoxide side chain exhibited a HETCOR coupling to 3-H of the pyrone (A) ring. In addition, couplings were seen between 16-H/15-CH3 of the epoxide and 3-H of the pyrone ring in the COSYexperiment. These would indicate the point of attachment of the side chain to be the same as that found in pluramycin type compounds. The side chain is structurally similar to that found in 14,16-epoxykidamycin (9), the largomycin FII chromophore12). However, a 2D XH NOE in a rotating frame (NOE-CAMEL)13)experiment, which shows an NOEcross peak between 16-H and 15-CH3 and the absence of a cross peak between the protons of the two methyl groups 15-CH3 and 17-CH3, strongly suggests that these methyl groups of the epoxide side chain maybe in the /raw-orientation, opposite that implied in reference 12 for the structure of 14,16-epoxykidamycin. This possible difference in stereochemisty is supported by differences in the 13C chemical shifts for carbons C-14 to C-17 (A3 2.2, 5.9, 0.7, 0.7, respectively) of 14,1 6-epoxykidamycin (9) and altromycin A (1); differences greater than might be expected due to the distal structural variances in these two molecules.
In addition to single frequency decoupling and total^-correlation spectroscopy (TOCSY) experiments, a combination of COSYand 2D-TOCSY14) data layed out in different colors on the same correlation map were used in determining the sequence of coupling systems for each sugar. Coupling constant and NOEdata were used to determine the relative configuration of each sugar ( Table 2 ). The neutral O-glycosyl moiety attached to the amino sugar is commonto altromycins A through D. This sugar contains two geminally coupled protons attached to the carbon near 3 30 (J2a'"-2b'" = 14Hz) and two axial-axial vicinally coupled protons, 4"'-H and 5"'-H (/4-_5-=9 Hz). 4'"-H shows a cross peak to 2b'"-H in the NOE-CAMEL experiment, indicating that these protons are orientated 1-3 axially to each other (Fig. 4) . 5"'-H and 3"'-OCH3 show the same type of 1-3 diaxial NOE. Taking into account that 2b "-3 "=3Hz and /3-_4» =3Hz, this neutral O-glycosidic sugar was denned as 2,6-dideoxy-3-0-methylaltrose.
The amino sugar in the altromycins was shownto be the same as that commonlyreported for the pluramycins; N,iV-dimethylvancosamine. This sugar, in the altromycin series, is found in a chair conformation based on coupling constants and NOEdata. A vicinal axial-axial coupling of /= 10 Hz is exhibited between the doublet at 3 5.5 (6"-H) and one of the two geminal protons 5b"-H (/5a,,_5b,, = MHz). A 1-3 diaxial cross peak is seen in the NOE-CAMEL experiment between 5b"-H and 3"-H. Additionally there is a 1-3-5 triaxial series of cross peaks between 6"-H, 2"-CH3 and the amino methyls of the vancosamine moiety. These data indicate that although the configuration of this sugar is the same as that reported for hedamycin (7) and kidamycin (8)15), it is in the chair conformation rather than the boat. This is presumably due to the substitution of C-3" with the glycosyloxy group..The degree of substitution of the amine on this sugar varies within the altromycins from monomethylated (altromycins A and C) to dimethylated (altromycins B and D). The C-glycosyl moiety attached to C-1 3 exhibits NOE-CAMEL cross peaks from the pseudoanomeric 6 '-H to both 4'-H and 2'-CH3 indicating a 1-3-5 triaxial relationship. The coupling constants J4. _5 ==9 Hz and /5,_6, = 9 Hz lead to the assignment of proton positions 4-6 as axial-axial-axial.
With this information and in consideration that /r_3,=2Hz, /3>_4 ==3Hz and an NOEis seen between 3'-H and 2'-CH3, this sugar was shown to be the C-glycoside of 6-deoxy-3-O-methylaltrose in altromycins A and B. In altromycins MAR. 1990 C and D, C-5' is found as a CH2 near 26ppm in the 13C NMRDEPT and HETCORexperiments (C-5' is ca. 67ppmCHOHin altromycins A and B). This accounts for the one less exchangeable proton found in altromycins C and D than in altromycins A and B. The neutral C-glycosyl moiety in altromycins C and D is therefore an analog of 2,6-dideoxy-3-0-methylaltrose.
Although the structures depicted in 1 through 4 show the sugars in the absolute stereochemistry as would be expected from D-glucose, no data to support this is available; nor is any data available on the absolute stereochemistry ofcarbons 1 3, 14 and 16.
The structures of the novel compounds altromycins A through D were determined to be that of 1~4 based on analysis of the spectroscopic data presented in this paper. The altromycins are set apart from previously reported pluramycin-type compoundsby virtue of a unique vancosamine-altrose analog disaccharide unit at the C-10 position of the chromophore, while C-8 of the chromophore is unsubstituted. An additional novel feature is seen in the presence of a C-glycoside analog of altrose attached to C-13 of the chromophore, found as both the 5'-hydroxy and 5'-deoxy version.
Experimental General Procedures
UVspectra were recorded on a Perkin-Elmer Lambda 3B UV/VISspectrophotometer, and IR spectra on a Perkin-Elmer 683 dual beam dispersive instrument. Optical rotations were measured in a 10-cm tube on a Perkin-Elmer model 241 polarimeter. Mass spectra were recorded on a Kratos MS-50spectrometer in the FABmode. Using TMSas an internal standard, NMRspectra were aquired employing a General Electric GN300or GN500spectrometer. *H NMRdata were acquired at 300 or 500MHzin CDC13. 13C NMRdata were taken at 75 or 125MHzin CDC13.
Isolation of the Altromycins
Whole broth (18liters), adjusted to pH 10.0 with NH4OH,was extracted three times with 4liter portions of methylene chloride. The methylene chloride extracts were combined and concentrated under reduced pressure on a vertical evaporator to approximately 4 g of oil. The concentrate was partitioned in the solvent system MeOH-H2O-CC14 (5 : 2 : 5) using a Square Coil Droplet Counter-Current device (made in-house) with the lower phase as the stationary. This device consists of 30mof continuous 3/16" ID teflon tubing wrapped in a 2 x 14cmrepeating pattern around an oak board. The coil has 96turns with a total internal volume of 450ml. Approximately one half volume is retained as stationary phase (by Gravity).
Material with substantial activity against P. aeruginosa was eluted with a flow rate of 5 ml/minute in fractions 26~80 (10~12 ml) which yielded approximately 255 mg and fractions 1 17~121 (10~12ml, beginning of stationary phase blow-out) which contained 570mg. Both activities were concentrated to orange-red oils. The activity from fractions 26~80 was partitioned on a CPCcounter-current device employing the following conditions: MeOH-H2O-CC14 (lower phase stationary, 5:2:5), tail inlet, 4ml/minute @800 rpm, 85~90% stationary retention, 10 ml fractions. Two areas of activity; fractions 35~41 (32.0 mg) and 71~105 (224.7mg) were obtained. The activity from 71~105 was rechromatographed on the CPC under the following conditions: MeOH-0.01 m NH4OAc-CC14 (lower phase stationary, 5 : 2 : 5), tail inlet, 4 ml/minute @800rpm, 85~90% stationary retention, 10 ml fractions. Two areas of activity were obtained: 16~21 (24.7mg, same compound as in 35~41)and 48~80 (230.4mg). Both were orange-red oils. Fractions 16~21 (35~41) contained altromycin A and fractions 48~80 altromycin B.
The activity from fractions 1 17~121 was partitioned on a CPCcounter-current device employing the following conditions: Hexane-EtOAc-MeOH-H2O(lower phase stationary, 3 : 7 : 6 :4), tail inlet, 4ml/minute @900 rpm 85~90% stationary retention, 8 ml fractions. One area of activity, fractions 37~45 was combined to yield 29.7mg of orange-red oil. These fractions contained altromycins C and D. They were chromatographed using the CPCunder the following conditions: Hexane -EtOAc-MeOH-0.01 m NH4OAc (lower phase stationary, 3 : 7: 6:4), tail inlet, 4ml/minute @900rpm, 85~90% stationary retention, 10ml fractions. Two areas of activity were obtained: 1 13 -121 contained 6.2mg of altromycin
